KR0130942B1 - Preparation process of 3-azido-3-deoxythimidine - Google Patents
Preparation process of 3-azido-3-deoxythimidineInfo
- Publication number
- KR0130942B1 KR0130942B1 KR1019940018690A KR19940018690A KR0130942B1 KR 0130942 B1 KR0130942 B1 KR 0130942B1 KR 1019940018690 A KR1019940018690 A KR 1019940018690A KR 19940018690 A KR19940018690 A KR 19940018690A KR 0130942 B1 KR0130942 B1 KR 0130942B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- compound
- added
- azido
- iii
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/067—Pyrimidine radicals with ribosyl as the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
본 발명은 항바이러스제 또는 에이즈 치료제로서 유용한 하기 일반식(Ⅰ)의 화합물의 새로운 제조방법에 관한 것이다.The present invention relates to a novel process for the preparation of compounds of formula (I) below which is useful as an antiviral or AIDS treatment.
상기 화합물을 제조하는 방법은 대한민국공개특허 제91-7919호, 일본공개특허소 제63-255295호 및 미합중국 특허 제5,108,993호 등에 기술되어 있다. 이들 공지의 제조방법에 따르면, 하기 반응도 Ⅰ에 나타내는 대로 티미딘(Thymidine)을 출발물질로하여 5‘위치의 수산기를 여러 가지 보호기를 이용하여 보호하고, 다시 3’위치의 수산기로 여러 가지 보호기를 이용하여 보호해준 후 아지드화제를 이용하여 3‘위치를 아지드화시키고 최종적으로 5’위치를 가수분해시키는 6단계의 공정을 거쳐 화합물(Ⅰ)을 제조한다. 따라서, 공지의 제조방법은 수산기의 보호 및 제거공정의 불합리성으로 인한 수율감소 및 제조공정이 복잡한 결점이 있다.Methods of preparing the compounds are described in Korean Patent Application Publication No. 91-7919, Japanese Patent Application Publication No. 63-255295, and US Patent No. 5,108,993. According to these known production methods, as shown in the following Reaction Scheme I, thymidine is used as a starting material to protect the hydroxyl group at the 5 'position using various protecting groups, and the various protecting groups are used as the hydroxyl group at the 3' position. After the protection, the compound (I) is prepared through a six-step process of azating the 3 'position using a azide agent and finally hydrolyzing the 5' position. Therefore, the known manufacturing method has a drawback in that the yield reduction and the manufacturing process are complicated due to the irrationality of the protection and removal process of the hydroxyl group.
(상기식에서, R은 트리틸기를, R1은 메실기를 의미한다)(Wherein R is a trityl group and R1 is a mesyl group)
따라서, 상기한 종래 방법의 결점을 보완하여 보다 공정을 단순화하고 공정의 수를 줄이므로써 총수율을 향상시켜 화합물(Ⅰ)을 제조할 수 있는 방법을 제공하고자 예의연구한 결과, O-아세틸 살리실로일 클로라이드를 이용하여 6 위치와 3‘위치를 고리화합물화시키면 그다음 반응에서 3’-과 5‘-위치의 수산기를 보호하지 않거나, 또는 5’위치의 수산기만을 보호한 후 반응을 진행시키므로써 상기 목적을 달성할 수 있음을 발견하고 본 발명을 완성하기에 이르렀다.Accordingly, as a result of earnest research to provide a method for preparing compound (I) by improving the total yield by simplifying the process and reducing the number of processes by supplementing the drawbacks of the conventional method described above, O-acetyl salicylic acid Cyclolation of the 6 and 3 'positions with siloyl chloride does not protect the hydroxyl groups at the 3'- and 5' positions in the next reaction, or only protects the hydroxyl groups at the 5 'position and then proceeds with the reaction. The present invention has been accomplished by discovering that the above object can be achieved.
즉, 본 발명의 목적은 티미딘으로부터 하기 일반식(Ⅰ)의 3‘-아지도-3’-데옥시 티미딘을 제조하는 방법에 있어서, 5‘-위치의 수산기가 트리틸기로 보호되어 있거나 (일반식(Ⅲ')의 화합물) 보호되지 않은 티미딘(일반식(Ⅲ)의 화합물)을 O-아세틸 살리실로일 클로라이드와 반응시켜 하기 일반식(Ⅱ) 또는 일반식(Ⅱ')의 화합물을 얻는 공정; 일반식(Ⅱ)또는 일반식(Ⅱ')의 화합물을 (PhO)2PON3 또는 Ph3P-NH3-디에틸 아조디카복시레이트와 반응시키는 공정; 및 필요에 따라 5’ 위치의 수사기의 보호기를 제거하는 공정을 포함함을 특징으로 하는 하기 일반식(Ⅰ)의 화합물을 제조하는 방법을 제공하는 것이다.That is, an object of the present invention is to prepare a 3'-azido-3'-deoxy thymidine of the general formula (I) from thymidine, wherein the hydroxyl group at the 5'-position is protected by a trityl group (Compound of formula (III ')) Unprotected thymidine (compound of formula (III)) is reacted with O-acetyl salicyloyl chloride to give a compound of formula (II) or formula (II') To obtain; Reacting a compound of formula (II) or formula (II ′) with (PhO) 2 PON 3 or Ph 3 P-NH 3 -diethyl azodicarboxylate; And if necessary, to provide a method for producing a compound of formula (I) characterized in that it comprises a step of removing the protecting group of the investigator at the 5 'position.
(상기 식중 5‘-위치가 -OR인 화합물은 (Ⅲ')이다.)(The compound in which 5′-position is —OR in the formula is (III ′).)
(상기 식중 5‘-위치가 -OR인 화합물은 (Ⅱ')이다.)(The compound whose 5'-position is -OR in the formula is (II ').)
(상기 식중에서, R은 트리틸기이다)(Wherein R is a trityl group)
이하 본 발명을 보다 상세히 설명한다.Hereinafter, the present invention will be described in more detail.
본 발명에 따른 방법을 반응도 Ⅱ에 나타내었다.The process according to the invention is shown in Scheme II.
반응도 ⅡReactivity Scheme II
본 발명의 방법에서는 티미딘을 그의 3‘- 또는 5’-위치의 수산기(-OH)를 보호하지 않은 채로 또는 5‘-위치의 수산기만을 트리틸기로 보호한 후에 O-아세틸 살리실로일 클로라이드와 반응시키므로써 6위치와 3’위치를 고리화합물화시킨다. 이렇게 고리화합물화하므로써 그 다음의 반응에 있어서 3‘-위치 및 5’-위치의 수산기를 보호하지 않고도 반응을 진행할 수 있다. 본 발명에서는 또한 3‘-위치를 아지드화할 때 디페닐 포스포닉 아지드(PhO)2PON3 또는 Ph3P-NH3-디에틸 아조디카복실레이트 착화합물을 아지드화제로 사용하므로써 반응을 안정적으로 진행할 수 있다. 반응후 얻어지는 목적 화합물은 그의 5’-위치의 수산기가 트리틸기로 보호된 경우에는 ((Ⅳ)의 화합물) 통상의 가수분해반응을 통하여 보호기인 트리틸기를 제거하여 최종 목적물질인 일반식(Ⅰ)의 화합물을 얻을 수 있다.In the method of the present invention, O-acetyl salicyloyl chloride is protected from thymidine without protecting its 3'- or 5'-position of hydroxyl group (-OH) or only the 5'-position of hydroxyl group with trityl group. By reacting with cyclizes the 6 and 3 'positions. This cyclization allows the reaction to proceed without protecting the hydroxyl groups at the 3'- and 5'-positions in subsequent reactions. In the present invention, the reaction can be stably progressed by using diphenyl phosphonic azide (PhO) 2 PON 3 or Ph 3 P-NH 3 -diethyl azodicarboxylate complex as an azide agent when azating the 3′-position. When the 5'-position hydroxyl group is protected by the trityl group, the target compound obtained after the reaction is removed through the normal hydrolysis reaction (compound (IV)). ) Compound can be obtained.
티미딘의 5‘-위치의 수산기를 트리틸기로 보호하고 탈보호하는 것은 공지의 방법에 따라 행할 수 있으며, 트리틸화제로는 트리틸클로라이드를 사용할 수 있다.Protecting and deprotecting the hydroxyl group at the 5'-position of thymidine with a trityl group can be carried out according to a known method, and trityl chloride can be used as the tritylating agent.
본 발명의 방법에 따른 반응은 테트라하이드로푸란, 염화 메틸렌, 아세토니트릴, 디메틸 포름아미드, N,N-디메틸 아세트아미드, 피리딘, 디옥산, 톨루엔, 벤젠, 디메틸 설폭사이드, 에테르, 에틸 아세테이트, 메탄올, 에탄올, 이소프로필 알콜 또는 부탄올로부터 선택된 1종 또는 2종 이상의 용매를 사용할 수 있다.The reaction according to the process of the present invention is tetrahydrofuran, methylene chloride, acetonitrile, dimethyl formamide, N, N-dimethyl acetamide, pyridine, dioxane, toluene, benzene, dimethyl sulfoxide, ether, ethyl acetate, methanol, One or two or more solvents selected from ethanol, isopropyl alcohol or butanol can be used.
이하 본 발명을 실시예에 의해 보다 상세히 설명하지만 본 발명이 이들 실시예에만 국한되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited to these Examples.
실시예 1Example 1
3구 플라스크에 아세토니트릴 100㎖를 가하고 티미딘 24g을 가한 다음, 완전히 용해된 후 O-아세틸 살리실로일 클로라이드 78g을 가해준 후 질소기류하에서 실온의 온도를 유지하며 24시간 교반하였다. 서서히 승온하여 65-75℃에서 1시간 유지시킨 후, 감압농축하여 아세토니트릴을 완전히 유거한 후 에테르 100㎕를 가해 1시간 교반해준 다음, 여과하여 잔사를 모았다.100 mL of acetonitrile was added to the three neck flask, and 24 g of thymidine was completely dissolved. Then, 78 g of O-acetyl salicyloyl chloride was added thereto, followed by stirring for 24 hours while maintaining a temperature of room temperature under a nitrogen stream. The mixture was gradually warmed up and maintained at 65-75 ° C. for 1 hour, concentrated under reduced pressure, completely distilled acetonitrile, and 100 µl of ether was added thereto, stirred for 1 hour, and filtered to collect the residue.
잔사에 0.5M-염산, 포화메탄올 620㎖를 가하고 실온에서 3일간 교반하였다. 여과하여 결정을 모으고 진공건조하여 일반식(Ⅱ)의 화합물 19.1g(85.6%)을 얻었다.0.5 M hydrochloric acid and 620 ml of saturated methanol were added to the residue, and the mixture was stirred at room temperature for 3 days. The crystals were collected by filtration and dried in vacuo to give 19.1 g (85.6%) of the compound of formula (II).
실시예 2Example 2
3구 플라스크에 디메틸 포름아미드 5.25g을 넣고 화합물(Ⅱ)4g을 넣어준 후 가열하여 80℃에서 0.5시간 교반한 후 디페닐 포스포닉 아지드(PhO)2PON3 0.61g을 넣어주고 5시간 가열 환류한 다음 냉각시켰다.5.25 g of dimethyl formamide was added to a three-necked flask, followed by 4 g of compound (II). The mixture was heated and stirred at 80 ° C. for 0.5 hour. Then, 0.61 g of diphenyl phosphonic azide (PhO) 2 PON 3 was added and refluxed for 5 hours. Then cooled.
5℃이하에서 증류수 30㎖를 넣어주고 5℃이하에서 1시간 교반하여 재결정해준 후 여과하여 증류수로 세척한 후 진공건조하여 일반식(Ⅰ)의 화합물 4.32g(91%)을 얻었다.30 ml of distilled water was added at 5 ° C. or lower, stirred for 1 hour at 5 ° C. or lower, recrystallized, filtered, washed with distilled water, and dried under vacuum to obtain 4.32 g (91%) of the compound of formula (I).
mp=121℃mp = 121 ℃
선광도=[α] + 50(C=1, in Water), [α] + 99(C=0.5 in Water)Luminous intensity = [α] + 50 (C = 1, in Water), [α] + 99 (C = 0.5 in Water)
UV max(water) : 266.5mm(Sol in hot methanol, hot ethanol)UV max (water): 266.5mm (Sol in hot methanol, hot ethanol)
1r(KBr) : 2100cml1r (KBr): 2100cml
실시예 3Example 3
3구 플라스크에스 트리페닐 포스핀 9g과 건조된 테트라하이드로푸란 20㎖를 혼합한 후 여기에 혼합물(Ⅱ)를 6.2g넣어준 후 냉각조 안에서 HN3 30㎖와 디메틸 아조디카복실레이트 5.3g을 1.2M벤젠용액으로 희석시킨 착화합물을 첨가후, -10℃에서 30시간 교반후, 0℃에서 2시간 교반하고, 실온에서 12시간 반응시켰다.After mixing 9 g of triphenyl phosphine and 20 ml of dried tetrahydrofuran, 6.2 g of mixture (II) was added thereto, and 1.2 M of 30 ml of HN3 and 5.3 g of dimethyl azodicarboxylate were added in a cooling bath. After adding the complex compound diluted with the benzene solution, after stirring at -10 degreeC for 30 hours, it stirred at 0 degreeC for 2 hours, and made it react at room temperature for 12 hours.
이 반응물을 농축하고, 잔유물에 클로로포름 30g을 넣어준 후 실리카겔컬럼을 이용하여 경제분리하므로써 일반식(Ⅰ)의 화합물 6.88g(92%)를 얻었다.The reaction product was concentrated, and 30 g of chloroform was added to the residue, followed by economic separation using a silica gel column to obtain 6.88 g (92%) of the compound of formula (I).
실시예 4Example 4
3구 플라스크에 피리딘 11.5g과 티미딘 5g을 넣어준 후, 여기에 트리틸클로라이드 5.9g을 가해주고 70℃에서 1시간, 80℃에서 1시간, 90℃에서 각각 1시간씩 반응시켰다. 이어 55℃에서 증류수 75㎖와 에틸아세트 75㎖의 혼합액을 넣어준 후 다시 층분리하고 0.5N염산 75㎖와 5%-탄산수소나트륨 75㎖, 그리고 증류수 75㎖로 차례로 씻어준 후, 분리하여 MgSO4 3.3g을 넣고 교반하였다. 여과후 에틸아세테이트로 세척하고 건조하여 일반식(Ⅲ')의 화합물 9.8g(98%)을 얻었다.After putting 11.5 g of pyridine and 5 g of thymidine into a three-necked flask, 5.9 g of trityl chloride was added thereto and reacted at 70 ° C. for 1 hour, at 80 ° C. for 1 hour, and at 90 ° C. for 1 hour. Subsequently, a mixed solution of 75 ml of distilled water and 75 ml of ethyl acetate was added at 55 ° C., followed by layer separation, followed by washing with 75 ml of 0.5N hydrochloric acid, 75 ml of 5% sodium bicarbonate, and 75 ml of distilled water, followed by separation. 3.3g was added and stirred. After filtration, washing with ethyl acetate and drying yielded 9.8 g (98%) of the compound of the general formula (III ').
실시예 5Example 5
3구 플라스크에 아세토니트릴 50㎖와 5‘-0-트리틸티미딘(Ⅲ') 10g을 용해시킨 후 O-아세틸 살리실로일 클로라이드 4.7g을 넣어준 후 질소기류하에서 24시간 실온에서 교반하였다.50 ml of acetonitrile and 10 g of 5'-0-tritylthymidine (III ') were dissolved in a three-necked flask, and 4.7 g of O-acetyl salicyloyl chloride was added thereto, followed by stirring at room temperature for 24 hours under a nitrogen stream.
가열하여 70℃에서 30분, 80℃에서 30분 각각 반응시킨후 감압농축하여 아세토니트릴을 회수하고 에테르 50㎕을 넣어준 후 실온에서 1시간 교반하여 일반식(Ⅱ')의 화합물 8.7g(90.2%)을 얻었다.After heating, the mixture was reacted for 30 minutes at 70 ° C. and 30 minutes at 80 ° C., and then concentrated under reduced pressure to recover acetonitrile, and 50 µl of ether was added thereto, followed by stirring at room temperature for 1 hour, to obtain 8.7 g of a compound of formula (II ′) (90.2). %) Was obtained.
실시예 6Example 6
3구 플라스크에 디메틸 포름아미드 12㎕를 넣어준 후 화합물(Ⅱ') 4g을 넣어준 후, 가열하여 80℃에서 1시간 교반한 후 디페닐포스포닉 아지드(PhO)2PON3) 0.32g을 넣어준 후 5시간 환류시켰다.12 μl of dimethyl formamide was added to a three-necked flask, followed by 4 g of compound (II ′). The mixture was heated and stirred at 80 ° C. for 1 hour, and then 0.32 g of diphenylphosphonic azide (PhO) 2 PON 3) was added thereto. After 5 hours reflux.
냉각시킨 후 증류수 20㎖를 서서히 넣어준 후 5℃이하에서 3시간 교반하여 재결정한 후, 여과하여 증류구 25㎖로 세척하고 건조시킨 후 일반식(Ⅳ)의 화합물 3.8g(87.2%)을 얻었다.After cooling, 20 ml of distilled water was slowly added thereto, stirred for 3 hours at 5 ° C. or lower, recrystallized, filtered, washed with 25 ml of distillation port, dried, and 3.8 g (87.2%) of Compound (IV) was obtained. .
실시예 7Example 7
3구 플라스크에 화합물(Ⅳ)3g을 넣고 아세톤 30㎖를 가해준 후 녹인다음 20%-염산 0.6㎖를 서서히 가해준 후 가열하여 45℃에서 5시간 반응시켰다. 반응완료후 20%-수산화나트륨 용액으로 pH를 7.0-8.0으로 조정해준 후, 진공 농축하여 아세톤을 완전히 제거하고 60℃에서 30분 교반하였다. 이어 여과하여 트리틸 알콜을 분리하고 여액을 60℃/70mmHg로 진공 농축하여 액량을 1/5로 줄인 후 소금으로 과포화 용액으로 만든다음 에틸 아세테이트 10㎖로 3회 세척, 분리해낸 후에 에틸아세테이층을 MgSo4 1g과 활성탄 0.6g을 넣어준 후 실온에서 2시간 교반 후 여과하였다. 이어 재결정을 행하고 다시 여과하여 건조시킨 후에 목적화합물(Ⅰ) 1.4g(89.1%)을 얻었다.3 g of compound (IV) was added to a three-necked flask, and 30 ml of acetone was added thereto, followed by melting. Then, 0.6 ml of 20% hydrochloric acid was added slowly, followed by heating at 45 ° C. for 5 hours. After completion of the reaction, the pH was adjusted to 7.0-8.0 with 20% sodium hydroxide solution, and then concentrated in vacuo to completely remove acetone and stirred at 60 ° C for 30 minutes. Subsequently, the trityl alcohol was separated by filtration, and the filtrate was concentrated in vacuo at 60 ° C./70 mmHg to reduce the liquid amount to 1/5, and then made into a supersaturated solution with salt, washed three times with 10 ml of ethyl acetate, and then separated, and then ethyl acetate layer. MgSo4 and 1g of activated carbon were added thereto, and the mixture was stirred at room temperature for 2 hours and then filtered. Subsequently, recrystallization was carried out and the filtrate was dried again to obtain 1.4 g (89.1%) of the target compound (I).
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019940018690A KR0130942B1 (en) | 1994-07-29 | 1994-07-29 | Preparation process of 3-azido-3-deoxythimidine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019940018690A KR0130942B1 (en) | 1994-07-29 | 1994-07-29 | Preparation process of 3-azido-3-deoxythimidine |
Publications (2)
Publication Number | Publication Date |
---|---|
KR960004359A KR960004359A (en) | 1996-02-23 |
KR0130942B1 true KR0130942B1 (en) | 1998-04-11 |
Family
ID=19389364
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019940018690A KR0130942B1 (en) | 1994-07-29 | 1994-07-29 | Preparation process of 3-azido-3-deoxythimidine |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR0130942B1 (en) |
-
1994
- 1994-07-29 KR KR1019940018690A patent/KR0130942B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR960004359A (en) | 1996-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0180415B1 (en) | A 6-0-methylerythromycin A derivative | |
AU2005320374B2 (en) | Method for the preparation of 2'-deoxy-2',2'-difluorocytidine | |
RU2439064C1 (en) | METHOD OF PRODUCING CAPECITABINE AND β-ANOMER RICH TRIALKYLCARBONATE COMPOUND USED THEREIN | |
JP3653292B2 (en) | Mass production of 2 ', 3'-didehydro-3'-deoxythymidine (d4T) using 5-methyluridine | |
RU2360919C2 (en) | Method of obtaining 2'-desoxy-2', 2'-difluorocytidine | |
KR20000057013A (en) | Novel Intermediates, process for preparing macrolide antibiotic agent therefrom | |
CA2228254C (en) | Process for producing erythromycin derivatives | |
KR0130942B1 (en) | Preparation process of 3-azido-3-deoxythimidine | |
KR100908363B1 (en) | Stereoselective preparation method of tri-O-acetyl-5-deoxy-β-D-ribofuranose and separation method thereof | |
JPH09165396A (en) | Production of 1-beta-d-arabinofuranosylcytosine | |
KR101259648B1 (en) | A manufacturing process of 2′,2′-difluoronucloside and intermediate | |
US20020146737A1 (en) | Nucleoside derivatives with photolabile protective groups | |
JP3258914B2 (en) | Method for producing erythromycin derivative | |
JPH08510228A (en) | Preparation of fluoro-nucleosides and intermediates for use therein | |
WO2004007518A1 (en) | Erythromycin a 9-o-pseudosaccharinyloxime derivatives and process for the preparation of clarithromycin using the same | |
JP3061476B2 (en) | Method for producing etoposide phosphate | |
KR100519498B1 (en) | Process for preparing etoposide | |
JPS61263995A (en) | Production of cytosine nucleoside | |
MX2007002284A (en) | Synthesis of idarubin aglycone. | |
WO2012018235A2 (en) | Method for preparing decitabine with improved yield and purity | |
JP3978006B2 (en) | Method for producing erythromycin derivative | |
JP5192807B2 (en) | Stable crystals of protected pseudouridine | |
WO2014088281A1 (en) | Novel method for preparing cabazitaxel from 10-deacetylbaccatin iii in high yield, and novel intermediate therefor | |
CN115505017A (en) | Synthesis method of etoposide and analogues thereof | |
JP2007204490A (en) | Process for producing erythromycin derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |